Publication | Open Access
Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
301
Citations
33
References
2011
Year
Selumetinib displays interesting activity and acceptable tolerability in patients with metastatic BC. Our results warrant further evaluation of selumetinib in patients with metastatic BC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1